Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand
Unchalee Permsuwan(Chiang Mai University), Maneerat Chayanupatkul(Chulalongkorn University), Ratree Sawangjit(Mahasarakham University), Tawesak Tanwandee(Siriraj Hospital), Pisit Tangkijvanich(Chulalongkorn University), Wattana Sukeepaisarnjaroen(Khon Kaen University), Pajaree Sriuttha(Chiang Mai University)
Cited by 5
Related Papers
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
|Gastroenterology|2017|929
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
|Gastroenterology|2018|796